Gilead Sciences (GILD) News Today $118.21 +1.03 (+0.88%) Closing price 10/13/2025 04:00 PM EasternExtended Trading$117.96 -0.25 (-0.21%) As of 09:19 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock GILD Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period TD Asset Management Inc Has $379.25 Million Holdings in Gilead Sciences, Inc. $GILD2 hours ago | marketbeat.comGilead Sciences, Inc. $GILD Shares Sold by Verdence Capital Advisors LLC4 hours ago | marketbeat.comJohnson Investment Counsel Inc. Has $1.58 Million Stake in Gilead Sciences, Inc. $GILD5 hours ago | marketbeat.comGilead Sciences, Inc. $GILD Shares Sold by IFP Advisors IncOctober 14 at 3:54 AM | marketbeat.comGilead Sciences/Arcus Biosciences' Investigational Cancer Drug Shows Overall Survival Of Around 27 MonthsOctober 13 at 10:50 AM | benzinga.comGilead Sciences/Arcus Biosciences' Investigational Cancer Drug Shows Overall Survival Of Around 27 MonthsOctober 13 at 10:33 AM | benzinga.comGilead and Kite Reinforce Bold Commitment to Transform Cancer Care With New Data at ESMO 2025October 13 at 9:06 AM | businesswire.comYousif Capital Management LLC Sells 2,855 Shares of Gilead Sciences, Inc. $GILDOctober 13 at 7:03 AM | marketbeat.comMOKAN Wealth Management Inc. Acquires 3,072 Shares of Gilead Sciences, Inc. $GILDOctober 13 at 6:46 AM | marketbeat.comConcurrent Investment Advisors LLC Grows Position in Gilead Sciences, Inc. $GILDOctober 13 at 6:18 AM | marketbeat.comTranscendent Capital Group LLC Invests $432,000 in Gilead Sciences, Inc. $GILDOctober 12 at 6:14 AM | marketbeat.comOFI Invest Asset Management Sells 86,817 Shares of Gilead Sciences, Inc. $GILDOctober 12 at 6:06 AM | marketbeat.comVanguard Personalized Indexing Management LLC Has $21.52 Million Stock Position in Gilead Sciences, Inc. $GILDOctober 12 at 5:46 AM | marketbeat.comGilead Sciences, Inc. $GILD Position Boosted by Sivik Global Healthcare LLCOctober 12 at 5:12 AM | marketbeat.comNatural Investments LLC Has $317,000 Holdings in Gilead Sciences, Inc. $GILDOctober 12 at 4:53 AM | marketbeat.comLmcg Investments LLC Has $1.97 Million Stock Position in Gilead Sciences, Inc. $GILDOctober 12 at 4:27 AM | marketbeat.comFY2025 EPS Estimate for Gilead Sciences Raised by AnalystOctober 12 at 2:09 AM | americanbankingnews.comHow Investors Are Reacting To Gilead Sciences (GILD) Extending Biktarvy Exclusivity and Advancing HIV, Oncology PipelineOctober 11 at 9:47 PM | uk.finance.yahoo.comFY2025 EPS Forecast for Gilead Sciences Increased by AnalystOctober 11 at 7:16 AM | marketbeat.comFourpath Capital Management LLC Reduces Stake in Gilead Sciences, Inc. $GILDOctober 11 at 7:16 AM | marketbeat.com3Chopt Investment Partners LLC Acquires 3,318 Shares of Gilead Sciences, Inc. $GILDOctober 11 at 6:30 AM | marketbeat.comConning Inc. Increases Stake in Gilead Sciences, Inc. $GILDOctober 11 at 6:14 AM | marketbeat.comGilead Sciences, Inc. $GILD Shares Sold by Aberdeen Group plcOctober 11 at 5:38 AM | marketbeat.comGilead Sciences (NASDAQ:GILD) Stock Unloaded Rep. Val T. HoyleOctober 11 at 5:02 AM | marketbeat.comGilead Sciences, Inc. (NASDAQ:GILD) Given Average Rating of "Moderate Buy" by AnalystsOctober 11 at 4:54 AM | marketbeat.comCantor Fitzgerald Issues Positive Forecast for Gilead Sciences (NASDAQ:GILD) Stock PriceOctober 10, 2025 | marketbeat.comTFR Capital LLC. Makes New $283,000 Investment in Gilead Sciences, Inc. $GILDOctober 10, 2025 | marketbeat.comTectonic Advisors LLC Increases Stake in Gilead Sciences, Inc. $GILDOctober 10, 2025 | marketbeat.comTrifecta Capital Advisors LLC Has $339,000 Stock Position in Gilead Sciences, Inc. $GILDOctober 10, 2025 | marketbeat.comCallan Family Office LLC Purchases 63,300 Shares of Gilead Sciences, Inc. $GILDOctober 10, 2025 | marketbeat.comBlair William & Co. IL Decreases Stock Holdings in Gilead Sciences, Inc. $GILDOctober 10, 2025 | marketbeat.comUS Bancorp DE Sells 22,670 Shares of Gilead Sciences, Inc. $GILDOctober 10, 2025 | marketbeat.comVontobel Holding Ltd. Lowers Holdings in Gilead Sciences, Inc. $GILDOctober 10, 2025 | marketbeat.comMaryland State Retirement & Pension System Increases Position in Gilead Sciences, Inc. $GILDOctober 10, 2025 | marketbeat.comGilead Sciences to Release Third Quarter 2025 Financial Results on Thursday, October 30, 2025October 9, 2025 | businesswire.comCitigroup Maintains Gilead Sciences (GILD) Buy RecommendationOctober 9, 2025 | msn.comFluent Financial LLC Raises Stake in Gilead Sciences, Inc. $GILDOctober 9, 2025 | marketbeat.comKingswood Wealth Advisors LLC Reduces Stock Position in Gilead Sciences, Inc. $GILDOctober 9, 2025 | marketbeat.comGilead Sciences (NASDAQ:GILD) Given "Buy (B)" Rating at Weiss RatingsOctober 9, 2025 | marketbeat.comGilead Sciences Sees Relative Strength Rating Rise To 72October 8, 2025 | msn.comBreaking Down Gilead Sciences: 6 Analysts Share Their ViewsOctober 8, 2025 | benzinga.comRoyal Bank Of Canada Increases Gilead Sciences (NASDAQ:GILD) Price Target to $100.00October 8, 2025 | marketbeat.comGilead Sciences (NASDAQ:GILD) Price Target Raised to $135.00 at CitigroupOctober 8, 2025 | marketbeat.com4 Bank of America Strong Buy Growth 10 Stocks That All Pay DividendsOctober 8, 2025 | 247wallst.comWESPAC Advisors LLC Purchases 7,248 Shares of Gilead Sciences, Inc. $GILDOctober 8, 2025 | marketbeat.comTriasima Portfolio Management inc. Increases Holdings in Gilead Sciences, Inc. $GILDOctober 8, 2025 | marketbeat.comFriedenthal Financial Purchases Shares of 9,152 Gilead Sciences, Inc. $GILDOctober 8, 2025 | marketbeat.comPrime Capital Investment Advisors LLC Decreases Holdings in Gilead Sciences, Inc. $GILDOctober 8, 2025 | marketbeat.comValeo Financial Advisors LLC Boosts Stake in Gilead Sciences, Inc. $GILDOctober 8, 2025 | marketbeat.comDAVENPORT & Co LLC Sells 16,332 Shares of Gilead Sciences, Inc. $GILDOctober 8, 2025 | marketbeat.com Get Gilead Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for GILD and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Videos GILD Media Mentions By Week GILD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GILD News Sentiment▼1.090.75▲Average Medical News Sentiment GILD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GILD Articles This Week▼5750▲GILD Articles Average Week Get the Latest News and Ratings for GILD and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Gilead Sciences and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies AMGN News Today LGND News Today MRNA News Today REGN News Today VIR News Today VRTX News Today ABBV News Today MRK News Today PFE News Today ALNY News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GILD) was last updated on 10/14/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredGold to $27,533?This week, U.S. gold reserves hit an unprecedented $1 TRILLION in value... And it's sparking urgent chatter...Stansberry Research | SponsoredRefund From 1933: Trump’s Reset May Create Instant WealthTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredThe Army Just Got a New Drone SupplierA cutting-edge drone developer just secured a U.S. Army deal to supply its Flex FPV Modular Drones and build a...The Tomorrow Investor | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredThis Crypto Is Set to Explode in JanuaryThe crypto summit Wall Street wants to stop Learn how to structure your portfolio like the top hedge funds...Crypto 101 Media | SponsoredWhat if your job didn’t matter — and neither did China’s chip ban?If you’ve been watching the headlines lately…You’ve seen how Nvidia and AMD just got the green light to resume...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Gilead Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Gilead Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
